These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8794405)
21. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
22. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer]. Zhang J; Zheng J; Fang W Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779 [TBL] [Abstract][Full Text] [Related]
23. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410 [TBL] [Abstract][Full Text] [Related]
24. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974 [TBL] [Abstract][Full Text] [Related]
25. The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways. Masuya D; Huang C; Liu D; Nakashima T; Yokomise H; Ueno M; Nakashima N; Sumitomo S J Pathol; 2006 Apr; 208(5):724-32. PubMed ID: 16450335 [TBL] [Abstract][Full Text] [Related]
26. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Kishimoto Y; Murakami Y; Shiraishi M; Hayashi K; Sekiya T Cancer Res; 1992 Sep; 52(17):4799-804. PubMed ID: 1324794 [TBL] [Abstract][Full Text] [Related]
27. Mutations of p53 gene in gastric carcinoma in Taiwan. Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797 [TBL] [Abstract][Full Text] [Related]
28. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients. Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123 [TBL] [Abstract][Full Text] [Related]
29. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay. Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807 [TBL] [Abstract][Full Text] [Related]
30. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas. Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509 [TBL] [Abstract][Full Text] [Related]
31. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708 [TBL] [Abstract][Full Text] [Related]
32. Genetic diversity at the p53 locus between primary human colorectal adenocarcinomas and their lymph-node metastases. Zhang JS; Caplin S; Bosman FT; Benhattar J Int J Cancer; 1997 Mar; 70(6):674-8. PubMed ID: 9096648 [TBL] [Abstract][Full Text] [Related]
34. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer. Hensel CH; Xiang RH; Sakaguchi AY; Naylor SL Oncogene; 1991 Jun; 6(6):1067-71. PubMed ID: 1648702 [TBL] [Abstract][Full Text] [Related]
35. Absence of p53 mutations in squamous carcinomas of the tongue in nonsmoking and nondrinking patients younger than 40 years. Sorensen DM; Lewark TM; Haney JL; Meyers AD; Krause G; Franklin WA Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):503-6. PubMed ID: 9158397 [TBL] [Abstract][Full Text] [Related]
36. Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas. Dai Y; Morishita Y; Mase K; Sato N; Akaogi E; Mitsui T; Noguchi M Cancer; 2000 Aug; 90(4):258-63. PubMed ID: 10966568 [TBL] [Abstract][Full Text] [Related]
37. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
38. Effect of non-tumor cell contamination on detection of p53 gene mutations in human gastric cancer cells by polymerase chain reaction single-strand conformation polymorphism analysis. Hong WS; Hong SI; Lee DS; Son Y Korean J Intern Med; 1994 Jan; 9(1):20-4. PubMed ID: 8038143 [TBL] [Abstract][Full Text] [Related]
39. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer. Huang CL; Taki T; Adachi M; Konishi T; Higashiyama M; Kinoshita M; Hadama T; Miyake M Int J Oncol; 1998 Mar; 12(3):553-63. PubMed ID: 9472092 [TBL] [Abstract][Full Text] [Related]
40. Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis. Keohavong P; Gao WM; Zheng KC; Mady H; Lan Q; Melhem M; Mumford J Anal Biochem; 2004 Jan; 324(1):92-9. PubMed ID: 14654050 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]